FERI (Luxembourg) S.A.’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.16M Buy
7,670
+680
+10% +$352K 0.56% 51
2026
Q2
$3.79M Buy
+6,990
New +$3.94M 0.6% 49
2025
Q2
– Sell
-2,990
Closed -$922K – 121
2025
Q1
$922K Buy
2,990
+2,027
+210% +$695K 0.32% 74
2024
Q4
$340K Sell
963
-27
-3% -$9.9K 0.19% 107
2024
Q3
$355K Sell
990
-220
-18% -$74.3K 0.2% 99
2024
Q2
$385K Buy
+1,210
New +$320K 0.25% 85

Other funds holding UTHR

FERI (Luxembourg) S.A.'s UTHR Position: Q3 2026 in Review

FERI (Luxembourg) S.A. increased its United Therapeutics (UTHR) stake by 9.7% in Q3 2026, buying an estimated $352K and bringing the position to 7,670 shares worth $4.16M. The position accounts for 0.56% of the portfolio, ranked #51.

FERI (Luxembourg) S.A. first reported a position in UTHR in Q2 2024 and has held it in 6 quarters since. 771 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • FERI (Luxembourg) S.A. held 7,670 shares of United Therapeutics worth $4.16M as of Q3 2026.
  • FERI (Luxembourg) S.A. bought 680 United Therapeutics shares in Q3 2026, an estimated $352K.
  • United Therapeutics made up 0.56% of FERI (Luxembourg) S.A.'s portfolio in Q3 2026, its #51 holding.
  • FERI (Luxembourg) S.A. first reported a position in United Therapeutics in Q2 2024 and has held it in 6 quarters since.
  • 771 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on FERI (Luxembourg) S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.